קאָמיסיע אַפּרוווז סלאָוואַקיש סכעמע פון ​​80 מיליאָן עוראָס צו שטיצן פאָרשונג, אַנטוויקלונג און טעסטינג ינפראַסטראַקטשער פֿאַר באַטייַטיק פּראָדוקטן פון # Coronavirus

The European Commission has approved a €80 million Slovak scheme to support industrial research and experimental development projects, as well as testing and upscaling infrastructures related to the production of coronavirus relevant products.The scheme was approved under the state aid צייטווייליגע פראַמעוואָרק. The public support will be co-financed by the European Structural and Investment Funds. It will take the form of direct grants and will be open to companies of all sizes, except financial institutions. The aim of the scheme is to enhance and accelerate the development and the production of products directly relevant to the coronavirus outbreak, including vaccines, hospital and medical equipment, medicinal products and protective equipment. The Commission found that the Slovak scheme is in line with the conditions set out in the Temporary Framework.

In particular, (i) the aid will cover a significant share of the costs of the eligible research and development (R&D) and investment projects; (ii) any result of the research activities will be made available, upon request, to third parties within the European Economic Area, through non-exclusive licences and under market conditions; and (iii) there will be a “bonus” (in terms of additional share of the costs that can be covered by the state aid) for R&D projects for industrial research and experimental development that are supported by more than one member state, or for projects that are carried out in cross-border collaboration with research organizations or other companies. The Commission concluded that the measure is necessary, appropriate and proportionate to fight the public health crisis, in line with Article 107(3)(c) TFEU and the conditions set out in the Temporary Framework. On this basis, the Commission approved the measures under EU state aid rules.

מער אינפֿאָרמאַציע וועגן די צייטווייליגע פראַמעוואָרק און אנדערע אַקשאַנז גענומען דורך די קאַמישאַן צו אַדרעס די עקאָנאָמיש פּראַל פון די קאָראַנדאַווירוס פּאַנדעמיק קענען זיין געפֿונען דאָ. די ניט-קאַנפאַדענשאַל ווערסיע פון ​​דעם באַשלוס וועט זיין בארעכטיגט אונטער די פאַל נומער SA.57829 אין די שטאַט הילף רעגיסטרירן אויף די קאַמישאַן ס קאָנקורענץ וועבזייַטל אַמאָל קיין פּריוואַטקייט ישוז האָבן שוין סאַלווד.

שער דעם אַרטיקל: